(Q44656714)

English

miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.

scientific article published on 10 November 2014

Statements

miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit